Commenting on the study for heartwire, antiplatelet expert Dr Victor Serebruany (HeartDrug Research, Towson, MD) said: "This is an extremely important paper with a clear clinical message—abrupt ...

Most panelists at the SCAI session said the accumulating data are convincing, and for some, they have led to changes in ...

In January 2008, Dr Steven Steinhubl announced that he was leaving his academic position to join The Medicines Company. Although Steinhubl had no official relationship with the company at the time he ...

Please provide your email address to receive an email when new articles are posted on . In early 2009, the FDA announced an ongoing safety review of clopidogrel after receiving reports that the use of ...

HOST-EXAM trial, a landmark study recently released at the ACC 2026. The trial sought to determine the effectiveness of ...

For decades, aspirin has been the go‑to drug for preventing heart attacks and strokes. But recent research is turning that assumption on its head. Aspirin has been overtaken by another well-known ...

Clopidogrel is prescribed to help prevent heart attack or stroke. It's a generic medication and is available as the brand-name drug Plavix. It comes as an oral tablet. The cost of clopidogrel can vary ...

Both aspirin and clopidogrel reduce the rate of cardiovascular events in patients with coronary heart disease. We estimated the cost effectiveness of the increased use of aspirin, clopidogrel, or both ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In a pooled cohort of the two STOPDAPT-2 trials, among ...

You have full access to this article via your institution. The Clopidogrel as Adjunctive Reperfusion Therapy–Thrombolysis In Myocardial Infarction study (CLARITY-TIMI) 28 trial was an international, ...

Background A 67-year-old man with supraventricular tachycardia associated with angina underwent coronary angiographic assessment. This investigation revealed mild coronary artery disease in his left ...

Gaspoz et al. (June 6 issue) 1 present an interesting perspective on the problem of escalating health care costs. Their comparison between the cost effectiveness of aspirin and that of clopidogrel is ...